Drug Pipeline

Lenacapavir Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT06532656
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1		 overall status: "Recruiting" → "Active Not Recruiting"
2026-06-05 NCT06532656
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1		 date change Primary completion pushed: 2028-02 -> 2030-07
2026-06-05 NCT06532656
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1		 date change Completion pushed: 2028-08 -> 2030-12
Active Studies by Phase
Phase 2/3
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06532656 Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 HIV-1-infection Active, Not Recruiting
Phase 1
NCT06819176 Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People… Human Immunodeficiency Virus Recruiting
Not specified
NCT07467018 Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles… HIV Prevention Recruiting
Sponsors Running Lenacapavir Trials
Gilead Sciences (1) National Institute of Allergy and Infectious Diseases (NIAID) (1) University of California, Los Angeles (1)
Get alerts when Lenacapavir trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free